Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Cancer Research UK
University of Nebraska
Cancer Research UK
Barbara Ann Karmanos Cancer Institute
Novartis
Stanford University
INSYS Therapeutics Inc